LY2886721

Can Biogen Catch up to Merck in Alzheimer's Race?
Motley Fool
Wed, 03/12/14 - 02:58 pm
Biogen Idec
Merck
Alzheimer's disease
E2609
bapineuzumab
LY2886721
Eli Lilly
Tecfidera
Which Alzheimer's Fighter Will Benefit From a Boost in Federal Funding?
Motley Fool
Mon, 09/30/13 - 04:29 pm
Alzheimer's disease
LY2886721
Eli Lilly
MK-8931
Merck
bapineuzumab
JNJ
solanezumab
Gammagard
Baxter International
Lilly halts Alzheimer's drug trial due to liver problems
Reuters
Fri, 06/14/13 - 08:07 am
LY2886721
Alzheimer's disease
Eli Lilly
Another Prospective Alzheimer's Trial
Seeking Alpha
Sat, 10/13/12 - 12:23 pm
solanezumab
Eli Lilly
LY2886721
gantenerumab
Roche